Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.910
-0.140 (-6.83%)
At close: Apr 21, 2026, 4:00 PM EDT
1.930
+0.020 (1.05%)
After-hours: Apr 21, 2026, 6:11 PM EDT
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $138.09 million as of April 21, 2026. Its market cap has increased by 88.48% in one year.
Market Cap
138.09M
Enterprise Value
84.59M
1-Year Change
88.48%
Ranking
Category
Stock Price
$1.91
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $138.09M, a decrease of -71.76%. That is a compound annual growth rate of -22.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 148.21M | 69.05% |
| Dec 31, 2025 | 87.67M | -37.65% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spero Therapeutics | 164.70M |
| Fate Therapeutics | 162.77M |
| Molecular Partners AG | 156.96M |
| Humacyte | 156.12M |
| Tiziana Life Sciences | 153.15M |
| Oramed Pharmaceuticals | 152.48M |
| Innate Pharma | 152.35M |
| Alpha Cognition | 152.20M |